AUDEARA LIMITED — Capital/Financing Update 2026

Mar 8, 2026

Highlights

• Purchase Orders from Clinico Inc. mark the commencement of three white-label commercial programs

• Programs include two Auracast™-enabled devices, including infrastructure built on Audeara’s newly launched BT-03 Audio Broadcaster platform

• New white-label initiatives expand on commercial success of Clinico Sound Earbuds CS1 launch in Taiwan

• Highlights ongoing delivery of strategy to scale AUA Technology division with commercial partnerships - comprising POs and product integrations - now underway with a pipeline of international customers

• Additional roll-out with Clinico provides additional sales channel through established Taiwanese partner and opportunity for broad top-line growth

• BT-03 Audio Broadcaster also launched in Australia at an MSRP of $399, with certification underway in other major markets including the US, Japan, Canada, and the EU.

• Early channel validation achieved in Australia with AV installers and consumer audio retailers allowing for potential to underpin ongoing revenue growth

Audeara Limited (ASX: AUA) (“ Audeara ” or “ the Company ”) is pleased to advise it has received purchase orders from Clinico Inc. (“Clinico”), marking the commencement of three white-label commercial programs intended for commercialisation and sale under the Clinico brand.

The programs include two Auracast™-enabled devices incorporating Audeara’s BT-03 Audio Broadcaster technology, with introductory orders of approximately $164,000 received to commence the program. Additional programs include a range of Clinico-branded packaging and accessories, as well as a separate Clinico-branded programming and interface tool.

The initiation of three additional commercialisation programs with the strategic counterparty follows the successful commercial deployment of the Clinico Sound Earbuds CS1 in Taiwan (refer ASX announcement: 4 October 2024) and represents an important step in scaling Audeara’s AUA Technology integration model.

Purchase orders received to-date reflect the continued commercial progression of the partnership, as well as the sales growth potential of Auracast™-enabled solutions into additional markets and deployment environments.

BT-03 Audio Broadcaster – Infrastructure for Auracast™

The Clinico white-label programs follow on from the recent commercial launch of Audeara’s BT03 Audio Broadcaster in Australia at a recommended retail price of $399, opening up an additional new sales channel in the domestic market.

The device broadcasts audio using the Bluetooth® LE Audio Auracast™ standard, enabling compatible personal listening devices to receive shared audio streams without individual pairing , supporting scalable shared listening experiences in public and commercial environments.

The BT-03 Audio Broadcaster has been designed to:

• Integrate seamlessly with existing AV systems;

• Enable scalable deployment across multi-room and multi-venue environments; and

• Support enhanced listening experiences for all users.

Following engagement with local distribution partners, certification processes are underway for the United States, Japan, Taiwan, Canada and the European Union.

From Product Launch to Ecosystem Deployment

Auracast™ adoption requires both broadcast infrastructure and compatible personal listening devices.

The BT-03 Audio Broadcaster addresses the infrastructure component, while Audeara Buds, BTLE Audio Transceivers and white-label partner devices enable the personalised listening layer.

The Clinico programs represent the integration of Audeara’s broadcast infrastructure within a partner’s commercial ecosystem, demonstrating how the Company’s technology can be embedded into third-party product portfolios.

Early channel validation for BT-03 Audio Broadcaster has been achieved through stocking by leading AV installers and consumer audio retailers in Australia, with international distributors preparing to onboard following certification.

==> picture [452 x 241] intentionally omitted <==

Audeara’s Auracast[TM] enabled product suite pictured from left to right: Audio Broadcaster, Audeara Buds, Audio Transceiver & Lapel Microphone

Target deployment environments include:

• Universities and education providers

• Clinical and aged care settings

• Hospitality and entertainment venues

• Schools and training facilities

Managing Director and Chief Executive Officer Dr James Fielding said:

“The receipt of purchase orders from Clinico reflects the continued strength of our partnership and the shared opportunity we identified as part of Clinico’s broader strategic investment.

Our Auracast™ transmitters are already deployed throughout leading global universities, and these programs represent the next step in scaling that infrastructure through white-label integration to target very lucrative consumer markets.

Having just returned from Integrated System Europe in Barcelona, meeting with a number of global Auracast product leaders, it was clear that there is a growing appetite for our technology offering, leaving Audeara very well placed to capitalise on the opportunity to transform listening and communication experiences.

We believe Auracast™ requires both infrastructure and devices to achieve meaningful adoption, and partnering with Clinico enables us to accelerate deployment within established regional channels.”

Scaling the AUA Technology Division

Audeara’s strategy is to scale its AUA Technology division by:

• Embedding its Auracast™ broadcast and audio DSP capabilities into partner product lines

• Expanding white-label and co-branded programs

• Leveraging infrastructure deployment to drive broader Auracast™ ecosystem adoption

The Company believes this integrated platform model supports diversified revenue growth and positions Audeara as a scalable Auracast™ technology partner globally.

This announcement has been authorised by the board of Audeara Limited.

For more information please visit, audeara.com

		INVESTOR & MEDIA ENQUIRIES	INVESTOR & MEDIA ENQUIRIES
	CORPORATE ENQUIRIES
	Dr James FieldingManaging Director and Chief Executive Officerjames.fielding@audeara.com		Henry JordanSix Degrees Investor Relationshenry.jordan@sdir.com.au

ABOUT AUDEARA

Feel connected, your way.

Audeara Limited (ASX: AUA) is a global hearing health leader specialised in innovative listening solutions for people with hearing challenges.

We are passionate about redefining hearing health, with a particular focus on delivering products that provide world-class tailored listening experiences.

We care about connecting people with experiences that bring them joy - whether that’s watching a favourite TV show, FaceTiming family or listening to music with confidence.

All Audeara products are purposefully designed and engineered in Australia with precision detail and state-of-the-art technology. Each product delivers optimum listening experiences to enhance quality of life for people of all ages and abilities.

Audeara sells its products through distributors and resellers in Australia, Europe, Asia and North America, and through e-commerce channels.